The first patient has been implanted in an investigational clinical study of STAAR Surgical’s EVO ICL family of lenses, according to a press release. EVO Visian IOLs are designed to treat a wide range of refractive error, including myopia, the release said. The...
OCALA, FL / ACCESSWIRE / February 5, 2020 / AIM ImmunoTech Inc. (NYSE American: AIM), an immuno-pharma company focused on the research and development of therapeutics to treat multiple types of cancers, today announced posting by the University of Pittsburgh Medical...
JERUSALEM, Feb. 5, 2020 /PRNewswire/ — BiondVax Pharmaceuticals Ltd. (Nasdaq: BVXV) announced today that preliminary data from the Phase 2 clinical trial of BiondVax’s M-001 universal influenza vaccine candidate have been published. The trial was supported...
WALTHAM, Mass., Feb. 05, 2020 (GLOBE NEWSWIRE) — Minerva Neurosciences, Inc. (NERV), a clinical-stage biopharmaceutical company focused on the development of therapies addressing high unmet medical needs in the treatment of central nervous system (CNS)...
NEW HAVEN, Conn., Feb. 05, 2020 (GLOBE NEWSWIRE) — BioXcel Therapeutics, Inc. (“BTI” or “Company”) (Nasdaq: BTAI), a clinical-stage biopharmaceutical company utilizing artificial intelligence approaches to identify and advance the next wave of medicines in...
Email
Text